Episode 278: PREMIUM – It’s all about the lungs
In episode 278, James and Mike get back to being PREMIUM podcasters and we discuss new studies around drugs for COPD, pneumonia, and smoking cessation. At the end we catch our breath and look back at how breathtaking this PREMIUM podcast all about lung issues truly was.
1) Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.
2) Antibiotic treatment strategies for community-acquired pneumonia in adults.
3) Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!